Artigo Revisado por pares

Oncodiagnosis Panel: 1999

2001; Radiological Society of North America; Volume: 21; Issue: 6 Linguagem: Italiano

10.1148/radiographics.21.6.g01nv311573

ISSN

1527-1323

Autores

Ritsuko Komaki, Marvin H. Chasen, William D. Travis, Joe B. Putnam, Frank V. Fossella, Roger W. Byhardt, Jae Y. Ro,

Tópico(s)

Lung Cancer Treatments and Mutations

Resumo

HomeRadioGraphicsVol. 21, No. 6 PreviousNext Plenary SessionOncodiagnosis Panel: 1999Cancer of the Lung: Oncodiagnosis1Ritsuko Komaki, Marvin H. Chasen, William D. Travis, Joe B. Putnam, Frank V. Fossella, Roger W. Byhardt, Jae Y. RoRitsuko Komaki, Marvin H. Chasen, William D. Travis, Joe B. Putnam, Frank V. Fossella, Roger W. Byhardt, Jae Y. RoAuthor Affiliations1From the Departments of Radiation Oncology (R.K.), Diagnostic Radiology (M.H.C.), Thoracic and Cardiovascular Surgery (J.B.P.), Thoracic/Head and Neck Medical Oncology (F.V.F.), and Pathology (J.Y.R.), University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 97, Houston, TX 77030; the Department of Pulmonary and Mediastinal Pathology, Armed Forces Institute of Pathology, Washington, DC (W.D.T.); and the Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee (R.W.B.). From the Oncodiagnosis Panel at the 1999 RSNA scientific assembly. Received March 5, 2001; revision requested April 2 and received May 21; accepted May 31. Address correspondence to R.K. (e-mail: [email protected]).Ritsuko KomakiMarvin H. ChasenWilliam D. TravisJoe B. PutnamFrank V. FossellaRoger W. ByhardtJae Y. RoPublished Online:Nov 1 2001https://doi.org/10.1148/radiographics.21.6.g01nv311573MoreSectionsFull textPDF ToolsImage ViewerAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinked In References 1 American Cancer Society. Cancer statistics. CA Cancer J Clin 2000; 50:12-32. Google Scholar2 Meyers CA, Byrne KS, Komaki R. Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer 1995; 12:231-236. Crossref, Medline, Google Scholar3 Quoix E, Fraser R, Wolkove N, Finkelstein H, Kreisman H. Small cell lung cancer presenting as a solitary pulmonary nodule. Cancer 1990; 66:577-582. Crossref, Medline, Google Scholar4 Kreisman H, Wolkove N, Quoix E. Small cell lung cancer presenting as a solitary pulmonary nodule. Chest 1992; 101:225-231. Crossref, Medline, Google Scholar5 Patz EF, Lowe VJ, Goodman PC, Herndon J. Thoracic nodal staging with PET imaging with 18-FDG in patients with bronchogenic carcinoma. Chest 1995; 108:1617-1621. Crossref, Medline, Google Scholar6 Scott WJ, Gobar LS, Terry JD, Dewan NA, Sunderland JJ. Mediastinal lymph node staging of non-small cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 1996; 111:642-648. Crossref, Medline, Google Scholar7 Gupta NC, Graeber GM, Rogers JS, 2nd, Bishop HA. Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer. Ann Surg 1999; 229:286-291. Crossref, Medline, Google Scholar8 Coleman RE. Clinical PET in oncology. Clin Positron Imaging 1998; 1:15-30. Crossref, Medline, Google Scholar9 Inoue T, Kim EE, Komaki R, et al. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995; 36:788-793. Medline, Google Scholar10 Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 1996; 37:943-948. Medline, Google Scholar11 Coleman RE. PET in lung cancer. J Nucl Med 1999; 40:814-820. Medline, Google Scholar12 Erasmus J, Patz EF, McAdams HP, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxy-glucose positron emission tomography. AJR Am J Roentgenol 1997; 168:1357-1360. Crossref, Medline, Google Scholar13 Erasmus JJ, McAdams HP, Patz EF, et al. Evaluation of primary pulmonary carcinoid tumors using positron emission tomography with 18F-fluorodeoxyglucose. AJR Am J Roentgenol 1998; 170:1369-1373. Crossref, Medline, Google Scholar14 Higashi K, Ueda Y, Seki H, et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med 1998; 39:1016-1020. Medline, Google Scholar15 Gambhir SS, Hoh CK, Phelps ME, Madar I, Maddahi J. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small cell lung cancer. J Nucl Med 1996; 37:1428-1436. Medline, Google Scholar16 Travis WD, Colby TV, Corrin B, et al. Histological typing of lung and pleural tumours World Health Organization International Histological Classification of Tumours. Berlin, Germany: Springer-Verlag, 1999. Google Scholar17 Travis WD, Rush W, Flieder DB, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998; 22:934-944. Crossref, Medline, Google Scholar18 Osterlind K, Hansen HH, Hansen M, et al. Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants. J Clin Oncol 1986; 4:1307-1313. Crossref, Medline, Google Scholar19 Arriagada R, Le Chevalier T, Pignon JP, et al. Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med 1993; 329:1848-1852. Crossref, Medline, Google Scholar20 Elias AD, Ayash L, Frei E, et al. Intensive combined modality therapy for limited stage small cell lung cancer. J Natl Cancer Inst 1993; 85:559-566. Crossref, Medline, Google Scholar21 McCracken JD, Janaki LM, Crowley JJ, et al. Concurrent chemotherapy/radiotherapy for limited small cell lung carcinoma: a Southwest Oncology Group study. J Clin Oncol 1992; 8:892-898. Google Scholar22 Turrisi AT, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999; 340:265-271. Crossref, Medline, Google Scholar23 Aisner J. Extensive disease small cell lung cancer: the thrill of victory, the agony of defeat. J Clin Oncol 1996; 14:658-665. Crossref, Medline, Google Scholar24 Siu LL, Shepherd FA, Murray N, et al. Influence of age on the treatment of limited stage small cell lung cancer. J Clin Oncol 1996; 14:821-828. Crossref, Medline, Google Scholar25 Carney DN. Lung cancer biology. Semin Radiat Oncol 1995; 5:4-10. Crossref, Medline, Google Scholar26 Stahel RA, Weber E. Small cell lung cancer: the new biology. Semin Radiat Oncol 1995; 5:11-18. Crossref, Medline, Google Scholar27 Paesmans M, Sculler JP, Lecomte J, et al. Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years. Cancer 2000; 89:523-533. Crossref, Medline, Google Scholar28 Bunn PA, Ihde DC. Small-cell bronchogenic carcinoma: a review of therapeutic results. In: Livingston RB, eds. Lung cancer. Vol 1. The Hague, The Netherlands: Martinus Nijhoff, 1981; 169-208. Google Scholar29 Lassen U, Hansen HH. Surgery in limited stage small cell lung cancer. Cancer Treat Rev 1999; 25:67-72. Crossref, Medline, Google Scholar30 Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111:1710-1717. Crossref, Medline, Google Scholar31 Namikawa S, Den T, Kimura M, Kusagawa M. The role of surgical resection and the effects of neo-adjuvant therapy in the management of small cell lung cancer. Surg Today 1994; 24:342-346. Crossref, Medline, Google Scholar32 Kohman LJ. Is there a place for surgery in central small cell lung cancer? Chest Surg Clin N Am 1997; 7:105-112. Medline, Google Scholar33 Lucchi M, Mussi A, Chella A, et al. Surgery in the management of small cell lung cancer. Eur J Cardiothorac Surg 1997; 12:689-693. Crossref, Medline, Google Scholar34 Urschel JD. Surgical treatment of peripheral small cell lung cancer. Chest Surg Clin N Am 1997; 7:95-103. Medline, Google Scholar35 Kobayashi S, Okada S, Hasumi T, Sato N, Fujimura S. Combined modality therapy including surgery for stage III small-cell lung cancer on the basis of the sensitivity assay in vitro. Surg Today 2000; 30:127-133. Crossref, Medline, Google Scholar36 Bonomi P. Review of selected randomized trials in small cell lung cancer. Semin Oncol 1998; 25(4 suppl 9):70-78. Google Scholar37 Fox W, Scadding JG. Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus: ten-year follow-up. Lancet 1973; 2:63-65. Medline, Google Scholar38 DeVore RF, Johnson DH. Chemotherapy of small cell lung cancer. Lung Cancer 1996; 56:825-898. Google Scholar39 Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992; 327:1618- 1624. Crossref, Medline, Google Scholar40 Komaki R. Management of limited small cell lung cancer. Int J Clin Oncol 2000; 5:205-216. Crossref, Google Scholar41 Choi NC, Herndon JE, Rosenman J, et al. Phase I study to determine the maximum tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited small-cell lung cancer. J Clin Oncol 1998; 16:3528-3536. Crossref, Medline, Google Scholar42 Turrisi AT, Glover DJ, Mason BA. A preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys 1988; 15:184-187. Google Scholar43 Kummermehr J, Dorr W, Trott KR. Kinetics of accelerated repopulation in normal and malignant squamous epithelium during fractionated therapy. BJR Suppl 1992; 24:193-199. Medline, Google Scholar44 Tannock IF. Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol 1989; 16:83-101. Crossref, Medline, Google Scholar45 Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27:131-146. Crossref, Medline, Google Scholar46 Goldie JH, Coldman AJ, Gudauskas GA. Rationale for the use of alternating non-cross resistant chemotherapy. Cancer Treat Rep 1982; 66:439-449. Medline, Google Scholar47 Murray N, Coy P, Pater J, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol 1993; 11:336-344. Crossref, Medline, Google Scholar48 Perry MC, Eaton WL, Propert KJ, et al. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med 1987; 316:912-918. Crossref, Medline, Google Scholar49 Turrisi A. Limited small cell lung cancer (LSCLC): concurrent BID thoracic radiotherapy (TRT) with platinum-etoposide (PE)—an ECOG study (abstr). Proceedings of the Annual Meeting of the American Society of Clinical Oncology. Alexandria, Va: American Society of Clinical Oncology, 1990; 230. Google Scholar50 Johnson BE, Bridges JD, Sobczeck M, et al. Patients with limited-stage small cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine. J Clin Oncol 1996; 14:806-813. Crossref, Medline, Google Scholar51 Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission: a meta-analysis of individual data from 987 patients. N Engl J Med 1999; 341:476-484. Crossref, Medline, Google Scholar52 Gregor A. Cranial irradiation in small cell lung cancer. Br J Cancer 1991; 63:13-14. Crossref, Medline, Google Scholar53 Komaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1995; 33:179-182. Crossref, Medline, Google Scholar54 Gregor A, Cull A, Stephens RJ, et al. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. Eur J Cancer 1997; 33:1752-1758. Crossref, Medline, Google Scholar55 Woodring JH. Determining the cause of pulmonary atelectasis: a comparison of plain radiography and CT. AJR Am J Roentgenol 1988; 150:757-763. Crossref, Medline, Google Scholar56 Naidich DP, Webb WR, Muller NL, et al. Lobar atelectasis. In: Naidich DP, Webb WR, Muller NL, Krinsky GA, Zerhouni EA, Siegelman SS, eds. Computed tomography and magnetic resonance imaging of the thorax. 3rd ed. Philadelphia, Pa: Lippincott, 1999; 228-241. Google Scholar57 Libshitz HI. Radiation changes in the lung. Semin Roentgenol 1993; 28:303-320. Crossref, Medline, Google Scholar58 Libshitz HI, Shuman LS. Radiation-induced pulmonary change: CT findings. J Comput Assist Tomogr 1984; 8:15-19. Crossref, Medline, Google Scholar59 Miller JD, Gorenstein LA, Patterson GA. Staging: the key to rational management of lung cancer. Ann Thorac Surg 1992; 53:170-178. Crossref, Medline, Google Scholar60 Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111:1718-1723. Crossref, Medline, Google Scholar61 Patterson GA, Piazza D, Pearson FG, et al. Significance of metastatic disease in subaortic lymph nodes. Ann Thorac Surg 1987; 43:155-159. Crossref, Medline, Google Scholar62 McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182:319-323. Link, Google Scholar63 American Joint Committee on Cancer. AJCC cancer staging manual 5th ed. Philadelphia, Pa: Lippincott-Raven, 1997; 127-137. Google Scholar64 Fowler WC, Langer CL, Curran WC, Keller SM. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 1993; 55:986-989. Crossref, Medline, Google Scholar65 Rusch VW, Albain KS, Crowley JJ, et al. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. J Thorac Cardiovasc Surg 1993; 105:97-106. Crossref, Medline, Google Scholar66 Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastasis to the brain: a randomized trial. JAMA 1998; 280:1485-1489. Crossref, Medline, Google Scholar67 Pisters KW, Ginsberg RJ, Bunn PA. Induction chemotherapy prior to surgery for early stage lung cancer: a novel approach (abstr). Proceedings of the 79th Annual Meeting of the American Association for Thoracic Surgery. Manchester, Mass: American Association for Thoracic Surgery, 1999; 140. Google Scholar68 Rosell R, Gomez-Condina J, Camps C, et al. A randomized trial of preoperative chemotherapy plus surgery versus surgery in non small cell lung cancer. N Engl J Med 1993; 330:153-158. Google Scholar69 Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994; 86:673-680. Crossref, Medline, Google Scholar70 Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma. Lung Cancer 1994; 10:S239-S244. Crossref, Medline, Google Scholar71 Dillman R, Seagren S, Propert K, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990; 323:940-945. Crossref, Medline, Google Scholar72 Sause W, Kolesar P, Taylor S, IV, et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 2000; 117:358-364. Crossref, Medline, Google Scholar73 Schaake-Koning C, Van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992; 326:524-530. Crossref, Medline, Google Scholar74 Byhardt R, Scott C, Ettinger D, et al. Concurrent hyperfractionation irradiation and chemotherapy for unresectable non-small cell lung cancer: results of Radiation Therapy Oncology Group 90-15. Cancer 1995; 75:2337-2344. Crossref, Medline, Google Scholar75 Lee J, Scott C, Komaki R, et al. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancer: RTOG protocol 91-06. J Clin Oncol 1996; 14:1055-1064. Crossref, Medline, Google Scholar76 Jeremic B, Jevremovic S, Mijatovic L, Milisavljevic S. Hyperfractionated radiation therapy with and without concurrent chemotherapy for advanced non-small cell lung cancer. Cancer 1993; 71:3732-3736. Crossref, Medline, Google Scholar77 Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent vs. sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol 1999; 17:2692-2699. Google Scholar78 Curran WJ, Jr, Scott C, Langer R, et al. Phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer (NSCLC): initial report of Radiation Therapy Oncology Group (RTOG) 9410 (abstr). In: Proceedings of the Annual Meeting of the American Society of Clinical Oncology. Alexandria, Va: American Society of Clinical Oncology, 2000; 484. Google Scholar79 Heelan RT, Demas BE, Caravelli JF, et al. Superior sulcus tumors: CT and MR imaging. Radiology 1989; 170:637-641. Link, Google Scholar80 Naidich DP, Webb WR, Muller NL, et al. Role of MR in staging lung cancer. In: Naidich DP, Webb WR, Muller NL, Krinsky GA, Zerhouni EA, Siegelman SS, eds. Computed tomography and magnetic resonance imaging of the thorax. 3rd ed. Philadelphia, Pa: Lippincott, 1999; 364-368. Google Scholar81 Attar S, Krasna MJ, Sonett JR, et al. Superior sulcus (Pancoast) tumor: experience with 105 patients. Ann Thorac Surg 1998; 66:193-198. Crossref, Medline, Google Scholar82 Strojan P, Debevec M, Kovac V. Superior sulcus tumor: management at the Institute of Oncology in Ljubljana, Slovenia 1981–1994. Lung Cancer 1997; 17:249-259. Crossref, Medline, Google Scholar83 Shaw RR, Paulson DL, Kee JL, Jr. Treatment of the superior sulcus tumor by irradiation followed by resection. Ann Surg 1961; 154:29-40. Crossref, Medline, Google Scholar84 Paulson DL. Technical considerations in stage III disease: the “superior sulcus” lesion. In: Delarue NC, Eschapasse H, eds. Lung cancer. Philadelphia, Pa: Saunders, 1985; 121-131. Google Scholar85 Miller JI, Mansour KA, Hatcher CR, Jr. Carcinoma of the superior pulmonary sulcus. Ann Thorac Surg 1979; 28:44-47. Crossref, Medline, Google Scholar86 Komaki R, Putnam JB, Jr, Walsh G, et al. The management of superior sulcus tumors. Semin Surg Oncol 2000; 18:152-164. Crossref, Medline, Google Scholar87 Herbert SH, Curran WJ, Jr, Stafford PM, et al. Comparison of outcome between clinically staged, unresected superior sulcus tumors and other stage III non-small cell lung carcinomas treated with radiation therapy alone. Cancer 1992; 69:363-369. Crossref, Medline, Google Scholar88 Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer: Lung Cancer Study Group. Ann Thorac Surg 1995; 60:615-623. Crossref, Medline, Google Scholar89 Ginsberg RJ. Resection of a superior sulcus tumor. Chest Surg Clin N Am 1995; 5:315-331. Medline, Google Scholar90 York JE, Walsh GL, Lang FF, et al. Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of Pancoast tumors. J Neurosurg 1999; 91(1 suppl):74-80. Medline, Google Scholar91 Gokaslan ZL, York JE, Walsh GL, et al. Transthoracic vertebrectomy for metastatic spinal tumors. J Neurosurg 1998; 89:599-609. Crossref, Medline, Google Scholar92 Dartevelle PG, Chapelier AR, Macchiarini P. Anterior transcervical-thoracic approach for radical resection of lung tumors invading the thoracic inlet. J Thorac Cardiovasc Surg 1993; 105:1025-1034. Crossref, Medline, Google Scholar93 Dartevelle P, Macchiarini P. Surgical management of superior sulcus tumors. Oncologist 1999; 4:398-407. Crossref, Medline, Google Scholar94 Kraut MJ, Rusch VW, Crowley JJ, Gandara DR. Induction chemoradiation plus surgical resection is a feasible and highly effective treatment for Pancoast tumors: initial results of SWOG 9416 (Intergroup 00160) trial (abstr). Proceedings of the Annual Meeting of the American Society of Clinical Oncology. Alexandria, Va: American Society of Clinical Oncology, 2000; 487. Google Scholar95 Paulson DL. Superior sulcus carcinomas. In: Sabiston DC, Sponsor FC, eds. Gibbon’s surgery of the chest. 4th ed. Philadelphia, Pa: Saunders, 1976; 506-515. Google Scholar96 Mountain CF. A new international staging system for lung cancer. Chest 1986; 89(4 suppl):225S-233S. Crossref, Medline, Google Scholar97 Komaki R. Preoperative radiation therapy for superior sulcus lesions. Chest Surg Clin N Am 1991; 1:13-35. Google Scholar98 Komaki R, Derus S, Perez-Tamayo C, Byhardt R, Hartz A, Cox J. Brain metastasis in patients with superior sulcus tumors. Cancer 1987; 59:1649-1653. Crossref, Medline, Google Scholar99 Komaki R, Mountain CF, Holbert JM, et al. Superior sulcus tumors: treatment selection and results for 85 patients without metastasis (M0) at presentation. Int J Radiat Oncol Biol Phys 1990; 19:31-36. Crossref, Medline, Google Scholar100 Sause W, Scott C, Taylor S, et al. Radiation Therapy Oncology Group (RTOG) and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 1995; 87:198-205. Crossref, Medline, Google Scholar101 Stoll BA, Andrews JT. Radiation-induced peripheral neuropathy. Br Med J 1966; 1:834-836. Crossref, Medline, Google Scholar102 Thomas JE, Colby MY. Radiation-induced or metastatic brachial plexopathy? A diagnostic dilemma. JAMA 1972; 222:1392-1395. Google ScholarArticle HistoryPublished in print: Nov 2001 FiguresReferencesRelatedDetailsCited ByGeriatric ImagingRobertaPolverosi, Pier CarloMuzzio, MatteoVincenzi, BenedettaRigoni2013Leibel and Phillips Textbook of Radiation OncologyRavinder K.Grewal, Kenneth E.Rosenzweig, Michelle S.Ginsberg2010Diffusion-weighted magnetic resonance imaging in differentiation of postobstructive consolidation from central lung carcinomaTamerBaysal, Deniz YakarMutlu, SaimYologlu2009 | Magnetic Resonance Imaging, Vol. 27, No. 10Radiologia geriatricaTommasoPirronti, RosariaPolito2006Small‐cell carcinoma of the lung resembling a brachial plexus tumourA. J. A.Ferreira, M. C.Peleteiro, J. H. D.Correia, S. O.Jesus, A.Goulão2005 | Journal of Small Animal Practice, Vol. 46, No. 6Recommended Articles RSNA Education Exhibits RSNA Case Collection Vol. 21, No. 6 Metrics Altmetric Score PDF download

Referência(s)
Altmetric
PlumX